Cellular and Molecular Neurobiology

Cellular and Molecular Neurobiology is a professional journal in neuroscience published by Springer. Founded in 1981, it focuses on the analysis of neuronal and brain function at the cellular and subcellular levels. It moved to fully open access in February 2024 and its current editor is Dr Juan M. Saavedra, MD, of Georgetown University Medical Center (United States)Cellular and Molecular Neurobiology 是 Springer 出版的神经科学专业期刊，1981 年创刊，聚焦神经元与脑功能在细胞与亚细胞层面的分析，采用混合与完全开放获取相结合的出版模式，2024 年 2 月起转为完全开放获取，现任主编为乔治城大学（美国）医学中心的 Juan M. Saavedra 医学博士。^[1]

Its CAS ranking has changed from year to year: the journal remained in the fourth tier of medicine in the 2024 and 2025 lists but rose to the third tier in the 2026 list, so any citation of its ranking should state the year on which it is based该刊的中科院分区逐年变动：在 2024 与 2025 年度均列医学四区，而在 2026 年的分区表中回升至三区，引用该刊的分区数据时需注明所依据的年度。

Scope

• 期刊定位为细胞与亚细胞层面神经元与脑功能分析的同行评审平台，所接受的稿件聚焦于神经元功能的分子机制而非一般神经科学叙述。
• 官方明确鼓励采用解剖学、遗传学、生理学与生物化学等多元路径研究神经元功能，强调多方法交叉的实验设计。
• 期刊特别鼓励以分离的哺乳动物组织与完整动物为对象的实验研究，并鼓励在单细胞层面解析分子机制或神经元反应。
• 论文体裁包括原创研究论文、综述、简报与会议摘要，另有以专题专刊形式组织的脑类器官、神经胶质细胞与神经调质等前沿方向。
• 稿件均经至少两位审稿人严格评审，期刊被医学文献数据库、Scopus 与科学引文索引扩展版等收录，投稿至首次决定的中位时长约五天。

The subjects listed above together express the trade-off of a narrowly scoped specialist title. It does not attempt to cover neuroscience in every direction, but requires each paper to anchor neuronal function in a specific molecular mechanism. The restriction to the cellular and subcellular level keeps the journal densely cited in areas such as single cell sequencing, cerebral organoids and ion channelsScope 章节所列主题共同体现了一本窄口径专业刊的取舍：它不追求神经科学的面面俱到，而是要求每一篇稿件都能把神经元的功能定位到明确的分子机制上。细胞与亚细胞层面的限定，使该刊在单细胞测序、脑类器官与离子通道等方向上保持了较高的引用密度。

History

• Late 1970s: George Stefano proposed starting a new scientific journal, initially with the subject matter limited to invertebrate neurobiology. On consideration the plan was judged too narrow and was not adopted1970 年代后期： George Stefano 提出创办新刊，最初设想把范围限定在无脊椎动物神经生物学，因过于狭窄而未采纳。

• 1981: The journal was founded with one of the initiators as its first editor-in-chief. Papers in volume 1 were primarily electrophysiological reports, studies of tissue culture of hybrid neurons or glia, and biochemical measurements of transmitter substances in nervous tissues1981 年： 正式创刊，首任主编由倡议人之一担任，首卷论文以电生理报告、杂交神经元或胶质细胞的组织培养以及神经组织中递质物质的生化测定为主。

• 1987: Juan Saavedra took over as editor-in-chief and remained in the post for many years, publishing a fortieth anniversary issue in 20211987 年： Juan Saavedra 接任主编，此后长期任职至 2021 年刊发创刊四十周年特刊。

• 2021: A fortieth anniversary issue traced four decades of change in neuroscience research, from electrophysiological and cellular methods towards molecular approaches and from animal models towards the direct study of human disease2021 年： 发表创刊四十周年特刊，回顾四十年来神经科学研究从电生理与细胞方法向分子方法、从动物模型向直接研究人类疾病的转变。

• 2024: Converted to fully open access, while continuing to organise themed collections on subjects such as artificial intelligence in neurodegenerative disease and the brain renin angiotensin system in ageing and neurodegeneration2024 年： 转为完全开放获取，期刊同时继续以专题专刊形式组织人工智能在神经退行性疾病中的应用、脑内肾素血管紧张素系统等方向。

The point of this history section is that the cellular and molecular positioning of the journal was not adopted retrospectively. When the journal was founded in 1981 molecular neuroscience was still in its infancy, and the founding editor later observed that it was fortunate to include the term molecular in the title. Four decades on, most papers in the journal concern molecular mechanisms in the nervous systemHistory 章节的意义在于说明该刊的细胞与分子定位并非事后追认。1981 年创刊时分子神经科学尚处于起步阶段，主编与同事当时即认为把分子二字写入刊名具有前瞻性，四十年后的论文主体已多为神经系统分子机制研究。

Editors

The editor is Juan M. Saavedra, MD, of the Department of Physiology and Pharmacology at Georgetown University Medical Center (United States). His field is neuropharmacology, covering the brain renin angiotensin system, neuroprotection and brain inflammation. He has been editor-in-chief since 1987 and is the longest serving editor of the journal现任主编为 Juan M. Saavedra 医学博士，任职于乔治城大学（美国）医学中心生理学与药理学系，研究方向为神经药理学，涵盖脑内血管紧张素系统、神经保护与脑部炎症等领域。他自 1987 年起担任主编，是该刊任期最长的编辑。

• Juan M. Saavedra, MD, is a professor in the Department of Physiology and Pharmacology at Georgetown University Medical Center (United States). His research focuses on brain and pituitary angiotensin, on disorders of the nervous system such as Alzheimer disease, and on how electrical or chemical stimulation changes neuronal responsesJuan M. Saavedra，医学博士，乔治城大学（美国）医学中心生理学与药理学系教授，研究聚焦脑与垂体血管紧张素、阿尔茨海默病等神经系统疾病。

• The journal also has a number of board members and associate editors from institutions including the School of Medicine at Sun Yat-sen University (China), covering neuroanatomy, neuroimmunology, ion channels and neurodegenerative disease期刊同时设有多位编委与副主编，来自中山大学医学院等机构，分属神经解剖、神经免疫、离子通道与神经退行性疾病等方向。

• The complete board list and submission requirements are available on the journal website. The journal uses anonymous peer review and all manuscripts are rigorously appraised by at least two referees before a decision is taken完整的编委名单与投稿要求见期刊官网，该刊采用匿名评审，所有稿件经至少两位审稿人严格评审后决定录用与否。^[2]